BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
Earnings
BioAge Labs's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Mar 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$300.00K
-85.7% on a year earlier
EPS, Q3 FY2026
-$0.73
-$0.56 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of BioAge Labs's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Mar 23, 2027Expected | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026after the close | $300.00K | -85.7% | -$0.73 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026after the close | $2.40M | -0.5% | -$0.58 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 8, 2026before the open | $2.80M | – | -$0.52 | Release |
| Q4 FY2025ended Dec 31, 2025 | Mar 24, 2026before the open | – | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 6, 2025after the close | $2.10M | – | -$0.56 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025after the close | $2.41M | – | -$0.60 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 6, 2025after the close | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 20, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024after the close | – | – | -$6.70 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
BioAge Labs has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When BioAge Labs puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases BioAge Labs filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Update
- Update
- Update
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?